CDKN2A and acute lymphoblastic leukemia: Consistently, inhibition of Notch signaling in T-ALL cell lines triggers upregulation of the cyclin-dependent kinase inhibitors CDKN2D (p19/INK4d) and CDKN1B (p27/Kip1) [35].